Table of Content

1 Report Overview
1.1 Anti-TNF-α Monoclonal Antibody Definition
1.2 Market by Type
1.2.1 Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Adalimumab
1.2.3 Golimumab
1.2.4 Infliximab
1.2.5 Pecerizumab
1.3 Market Segment by Application
1.3.1 Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Rheumatoid Arthritis
1.3.3 Ankylosing Spondylitis
1.3.4 Psoriasis
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Anti-TNF-α Monoclonal Antibody Sales
2.1 Global Anti-TNF-α Monoclonal Antibody Revenue Estimates and Forecasts 2018-2034
2.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Anti-TNF-α Monoclonal Antibody Revenue by Region
2.3.1 Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2018-2024)
2.3.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2024-2034)
2.4 Global Anti-TNF-α Monoclonal Antibody Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Region
2.6.1 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Region (2018-2024)
2.6.2 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Manufacturers
3.1.1 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Anti-TNF-α Monoclonal Antibody Sales in 2022
3.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers
3.2.1 Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers (2018-2024)
3.2.2 Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-TNF-α Monoclonal Antibody Revenue in 2022
3.3 Global Anti-TNF-α Monoclonal Antibody Sales Price by Manufacturers
3.4 Global Key Players of Anti-TNF-α Monoclonal Antibody, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Type
4.1.1 Global Anti-TNF-α Monoclonal Antibody Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
4.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Type
4.2.1 Global Anti-TNF-α Monoclonal Antibody Historical Revenue by Type (2018-2024)
4.2.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Revenue by Type (2024-2034)
4.2.3 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
4.3 Global Anti-TNF-α Monoclonal Antibody Price by Type
4.3.1 Global Anti-TNF-α Monoclonal Antibody Price by Type (2018-2024)
4.3.2 Global Anti-TNF-α Monoclonal Antibody Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Application
5.1.1 Global Anti-TNF-α Monoclonal Antibody Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
5.2 Global Anti-TNF-α Monoclonal Antibody Revenue by Application
5.2.1 Global Anti-TNF-α Monoclonal Antibody Historical Revenue by Application (2018-2024)
5.2.2 Global Anti-TNF-α Monoclonal Antibody Forecasted Revenue by Application (2024-2034)
5.2.3 Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
5.3 Global Anti-TNF-α Monoclonal Antibody Price by Application
5.3.1 Global Anti-TNF-α Monoclonal Antibody Price by Application (2018-2024)
5.3.2 Global Anti-TNF-α Monoclonal Antibody Price Forecast by Application (2024-2034)
6 North America
6.1 North America Anti-TNF-α Monoclonal Antibody Sales by Company
6.1.1 North America Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024)
6.1.2 North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024)
6.2 North America Anti-TNF-α Monoclonal Antibody Market Size by Type
6.2.1 North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2034)
6.2.2 North America Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2034)
6.3 North America Anti-TNF-α Monoclonal Antibody Market Size by Application
6.3.1 North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2034)
6.3.2 North America Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2034)
6.4 North America Anti-TNF-α Monoclonal Antibody Market Size by Country
6.4.1 North America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2034)
6.4.3 North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Anti-TNF-α Monoclonal Antibody Sales by Company
7.1.1 Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024)
7.1.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024)
7.2 Europe Anti-TNF-α Monoclonal Antibody Market Size by Type
7.2.1 Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2034)
7.2.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2034)
7.3 Europe Anti-TNF-α Monoclonal Antibody Market Size by Application
7.3.1 Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2034)
7.3.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2034)
7.4 Europe Anti-TNF-α Monoclonal Antibody Market Size by Country
7.4.1 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2034)
7.4.3 Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Anti-TNF-α Monoclonal Antibody Sales by Company
8.1.1 China Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024)
8.1.2 China Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024)
8.2 China Anti-TNF-α Monoclonal Antibody Market Size by Type
8.2.1 China Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2034)
8.2.2 China Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2034)
8.3 China Anti-TNF-α Monoclonal Antibody Market Size by Application
8.3.1 China Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2034)
8.3.2 China Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Anti-TNF-α Monoclonal Antibody Sales by Company
9.1.1 APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024)
9.1.2 APAC Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024)
9.2 APAC Anti-TNF-α Monoclonal Antibody Market Size by Type
9.2.1 APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2034)
9.2.2 APAC Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2034)
9.3 APAC Anti-TNF-α Monoclonal Antibody Market Size by Application
9.3.1 APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2034)
9.3.2 APAC Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2034)
9.4 APAC Anti-TNF-α Monoclonal Antibody Market Size by Region
9.4.1 APAC Anti-TNF-α Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Anti-TNF-α Monoclonal Antibody Revenue by Region (2018-2034)
9.4.3 APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales by Company
10.1.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Market Size by Type
10.2.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Market Size by Application
10.3.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Market Size by Country
10.4.1 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Abbive
11.1.1 Abbive Company Information
11.1.2 Abbive Overview
11.1.3 Abbive Anti-TNF-α Monoclonal Antibody Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Abbive Anti-TNF-α Monoclonal Antibody Products and Services
11.1.5 Abbive Anti-TNF-α Monoclonal Antibody SWOT Analysis
11.1.6 Abbive Recent Developments
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Information
11.2.2 Johnson and Johnson Overview
11.2.3 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Johnson and Johnson Anti-TNF-α Monoclonal Antibody Products and Services
11.2.5 Johnson and Johnson Anti-TNF-α Monoclonal Antibody SWOT Analysis
11.2.6 Johnson and Johnson Recent Developments
11.3 UCB
11.3.1 UCB Company Information
11.3.2 UCB Overview
11.3.3 UCB Anti-TNF-α Monoclonal Antibody Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 UCB Anti-TNF-α Monoclonal Antibody Products and Services
11.3.5 UCB Anti-TNF-α Monoclonal Antibody SWOT Analysis
11.3.6 UCB Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Anti-TNF-α Monoclonal Antibody Value Chain Analysis
12.2 Anti-TNF-α Monoclonal Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-TNF-α Monoclonal Antibody Production Mode & Process
12.4 Anti-TNF-α Monoclonal Antibody Sales and Marketing
12.4.1 Anti-TNF-α Monoclonal Antibody Sales Channels
12.4.2 Anti-TNF-α Monoclonal Antibody Distributors
12.5 Anti-TNF-α Monoclonal Antibody Customers
13 Market Dynamics
13.1 Anti-TNF-α Monoclonal Antibody Industry Trends
13.2 Anti-TNF-α Monoclonal Antibody Market Drivers
13.3 Anti-TNF-α Monoclonal Antibody Market Challenges
13.4 Anti-TNF-α Monoclonal Antibody Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Adalimumab
Table 3. Major Manufacturers of Golimumab
Table 4. Major Manufacturers of Infliximab
Table 5. Major Manufacturers of Pecerizumab
Table 6. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Anti-TNF-α Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2018-2024)
Table 10. Global Anti-TNF-α Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region (2024-2034)
Table 12. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Region: 2018 VS 2022 VS 2034 (KG)
Table 13. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2018-2024) & (KG)
Table 14. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2018-2024)
Table 15. Global Anti-TNF-α Monoclonal Antibody Sales by Region (2024-2034) & (KG)
Table 16. Global Anti-TNF-α Monoclonal Antibody Sales Market Share by Region (2024-2034)
Table 17. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Manufacturers (2018-2024) & (KG)
Table 18. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Anti-TNF-α Monoclonal Antibody Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Manufacturers (2018-2024)
Table 21. Global Anti-TNF-α Monoclonal Antibody Price by Manufacturers 2018-2024 (USD/KG)
Table 22. Global Key Players of Anti-TNF-α Monoclonal Antibody, Industry Ranking, 2021 VS 2022
Table 23. Global Anti-TNF-α Monoclonal Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Anti-TNF-α Monoclonal Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-TNF-α Monoclonal Antibody as of 2022)
Table 25. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Product Offered and Application
Table 27. Global Key Manufacturers of Anti-TNF-α Monoclonal Antibody, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 30. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 31. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Type (2018-2024)
Table 32. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Type (2024-2034)
Table 33. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Type (2018-2024)
Table 36. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Type (2024-2034)
Table 37. Anti-TNF-α Monoclonal Antibody Price by Type (2018-2024) & (USD/KG)
Table 38. Global Anti-TNF-α Monoclonal Antibody Price Forecast by Type (2024-2034) & (USD/KG)
Table 39. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 40. Global Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 41. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Application (2018-2024)
Table 42. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Application (2024-2034)
Table 43. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Application (2018-2024)
Table 46. Global Anti-TNF-α Monoclonal Antibody Revenue Share by Application (2024-2034)
Table 47. Anti-TNF-α Monoclonal Antibody Price by Application (2018-2024) & (USD/KG)
Table 48. Global Anti-TNF-α Monoclonal Antibody Price Forecast by Application (2024-2034) & (USD/KG)
Table 49. North America Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024) & (KG)
Table 51. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 52. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 53. North America Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 56. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 57. North America Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Anti-TNF-α Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2024) & (KG)
Table 63. North America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2024-2034) & (KG)
Table 64. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024) & (KG)
Table 65. Europe Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 67. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 68. Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 71. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 72. Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Anti-TNF-α Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2024) & (KG)
Table 78. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2024-2034) & (KG)
Table 79. China Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024) & (KG)
Table 80. China Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 82. China Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 83. China Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 86. China Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 87. China Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024) & (KG)
Table 90. APAC Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 92. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 93. APAC Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 96. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 97. APAC Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Anti-TNF-α Monoclonal Antibody Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Anti-TNF-α Monoclonal Antibody Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Anti-TNF-α Monoclonal Antibody Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Region (2018-2024) & (KG)
Table 103. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity by Region (2024-2034) & (KG)
Table 104. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Company (2018-2024) & (KG)
Table 105. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2018-2024) & (KG)
Table 107. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Type (2024-2034) & (KG)
Table 108. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2018-2024) & (KG)
Table 111. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Application (2024-2034) & (KG)
Table 112. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2018-2024) & (KG)
Table 118. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity by Country (2024-2034) & (KG)
Table 119. Abbive Company Information
Table 120. Abbive Description and Overview
Table 121. Abbive Anti-TNF-α Monoclonal Antibody Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 122. Abbive Anti-TNF-α Monoclonal Antibody Product and Services
Table 123. Abbive Anti-TNF-α Monoclonal Antibody SWOT Analysis
Table 124. Abbive Recent Developments
Table 125. Johnson and Johnson Company Information
Table 126. Johnson and Johnson Description and Overview
Table 127. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 128. Johnson and Johnson Anti-TNF-α Monoclonal Antibody Product and Services
Table 129. Johnson and Johnson Anti-TNF-α Monoclonal Antibody SWOT Analysis
Table 130. Johnson and Johnson Recent Developments
Table 131. UCB Company Information
Table 132. UCB Description and Overview
Table 133. UCB Anti-TNF-α Monoclonal Antibody Sales Quantity (KG), Revenue (US$ Million), Average Selling Price (ASP) (USD/KG) and Gross Margin (2018-2024)
Table 134. UCB Anti-TNF-α Monoclonal Antibody Product and Services
Table 135. UCB Anti-TNF-α Monoclonal Antibody SWOT Analysis
Table 136. UCB Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Anti-TNF-α Monoclonal Antibody Distributors List
Table 140. Anti-TNF-α Monoclonal Antibody Customers List
Table 141. Anti-TNF-α Monoclonal Antibody Market Trends
Table 142. Anti-TNF-α Monoclonal Antibody Market Drivers
Table 143. Anti-TNF-α Monoclonal Antibody Market Challenges
Table 144. Anti-TNF-α Monoclonal Antibody Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-TNF-α Monoclonal Antibody Product Picture
Figure 2. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-TNF-α Monoclonal Antibody Market Share by Type in 2022 & 2034
Figure 4. Adalimumab Product Picture
Figure 5. Golimumab Product Picture
Figure 6. Infliximab Product Picture
Figure 7. Pecerizumab Product Picture
Figure 8. Global Anti-TNF-α Monoclonal Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Anti-TNF-α Monoclonal Antibody Market Share by Application in 2022 & 2034
Figure 10. Rheumatoid Arthritis
Figure 11. Ankylosing Spondylitis
Figure 12. Psoriasis
Figure 13. Other
Figure 14. Anti-TNF-α Monoclonal Antibody Report Years Considered
Figure 15. Global Anti-TNF-α Monoclonal Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 16. Global Anti-TNF-α Monoclonal Antibody Revenue 2018-2034 (US$ Million)
Figure 17. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 18. Global Anti-TNF-α Monoclonal Antibody Sales Quantity 2018-2034 (KG)
Figure 19. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Region (2018-2024)
Figure 20. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Anti-TNF-α Monoclonal Antibody Sales Quantity YoY (2018-2034) & (KG)
Figure 22. North America Anti-TNF-α Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity YoY (2018-2034) & (KG)
Figure 24. Europe Anti-TNF-α Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Anti-TNF-α Monoclonal Antibody Sales Quantity YoY (2018-2034) & (KG)
Figure 26. China Anti-TNF-α Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity YoY (2018-2034) & (KG)
Figure 28. APAC Anti-TNF-α Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity YoY (2018-2034) & (KG)
Figure 30. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Anti-TNF-α Monoclonal Antibody Sales Quantity in 2022
Figure 32. The Top 10 and Top 5 Players Market Share by Anti-TNF-α Monoclonal Antibody Revenue in 2022
Figure 33. Anti-TNF-α Monoclonal Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 36. Global Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 38. North America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 39. North America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Company in 2022
Figure 40. North America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 42. North America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 44. North America Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 45. North America Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Country (2018-2034)
Figure 46. United States Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Company in 2022
Figure 49. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 50. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 52. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 54. Europe Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 55. Europe Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 57. France Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 61. China Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Company in 2022
Figure 62. China Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 63. China Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 65. China Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 67. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Company in 2022
Figure 68. APAC Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 69. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 71. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 73. APAC Anti-TNF-α Monoclonal Antibody Revenue Share by Region (2018-2034)
Figure 74. APAC Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 79. India Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Company in 2022
Figure 82. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Anti-TNF-α Monoclonal Antibody Revenue Share by Country (2018-2034)
Figure 88. Brazil Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Anti-TNF-α Monoclonal Antibody Revenue (2018-2034) & (US$ Million)
Figure 93. Anti-TNF-α Monoclonal Antibody Value Chain
Figure 94. Anti-TNF-α Monoclonal Antibody Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed